Nath Bio-Genes (I) EBIT per Share
The EBIT per Share of Nath Bio-Genes (I) (NATHBIOGEN.NS) as of Oct 29, 2026 is 25.51 INR. In the previous year, EBIT per Share was 24.20 INR — a change of 5.42% (higher).
Get this data via API
Financial Data API
EBIT per Share
25.51INR
YoY
5.42%
Last updated:
The Nath Bio-Genes (I) EBIT per Share history
3 Years
10 Years
25 Years
Max
| YEAR | EBIT per Share | YoY |
|---|---|---|
| est | 50.70INR | +11.12% |
| est | 45.63INR | +9.24% |
| est | 41.77INR | +3.00% |
| est | 40.55INR | +58.99% |
| 25.51INR | +5.42% | |
| 24.20INR | +1.08% | |
| 23.94INR | -2.05% | |
| 24.44INR | -66.25% | |
| 72.41INR | +110.55% | |
| 34.39INR | +22.74% | |
| 28.02INR | +27.06% | |
| 22.05INR | +1.00% | |
| 21.83INR | -3.54% | |
| 22.64INR | +69.48% | |
| 13.36INR | -29.62% | |
| 18.98INR | +20.15% | |
| 15.80INR | +105.32% | |
| 7.69INR | +35.67% | |
| 5.67INR | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Nath Bio-Genes (I) Stock analysis
Frequently Asked Questions about Nath Bio-Genes (I) stock
EBIT per Share of Nath Bio-Genes (I) is 25.51 INR in 2026.
EBIT per Share of Nath Bio-Genes (I) changed from 24.20 INR to 25.51 INR, representing a 5.42% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Nath Bio-Genes (I) since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — Nath Bio-Genes (I)
All Key Metrics — Nath Bio-Genes (I)
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth